<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Interv Aging</journal-id><journal-id journal-id-type="iso-abbrev">Clin Interv Aging</journal-id><journal-id journal-id-type="publisher-id">Clinical Interventions in Aging</journal-id><journal-title-group><journal-title>Clinical Interventions in Aging</journal-title></journal-title-group><issn pub-type="ppub">1176-9092</issn><issn pub-type="epub">1178-1998</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29662308</article-id><article-id pub-id-type="pmc">5892965</article-id><article-id pub-id-type="doi">10.2147/CIA.S157584</article-id><article-id pub-id-type="publisher-id">cia-13-523</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Hypoglycemic and antioxidant effect of Tai chi exercise training in older adults with metabolic syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mendoza-N&#x000fa;&#x000f1;ez</surname><given-names>V&#x000ed;ctor Manuel</given-names></name><xref ref-type="aff" rid="af1-cia-13-523">1</xref><xref ref-type="corresp" rid="c1-cia-13-523"/></contrib><contrib contrib-type="author"><name><surname>Arista-Ugalde</surname><given-names>Taide Laurita</given-names></name><xref ref-type="aff" rid="af1-cia-13-523">1</xref></contrib><contrib contrib-type="author"><name><surname>Rosado-P&#x000e9;rez</surname><given-names>Juana</given-names></name><xref ref-type="aff" rid="af1-cia-13-523">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruiz-Ramos</surname><given-names>Mirna</given-names></name><xref ref-type="aff" rid="af1-cia-13-523">1</xref></contrib><contrib contrib-type="author"><name><surname>Santiago-Osorio</surname><given-names>Edelmiro</given-names></name><xref ref-type="aff" rid="af2-cia-13-523">2</xref></contrib></contrib-group><aff id="af1-cia-13-523">
<label>1</label>Research Unit on Gerontology, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico</aff><aff id="af2-cia-13-523">
<label>2</label>Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico</aff><author-notes><corresp id="c1-cia-13-523">Correspondence: V&#x000ed;ctor Manuel Mendoza-N&#x000fa;&#x000f1;ez, Facultad de Estudios Superiores Zaragoza, UNAM, Unidad de Investigaci&#x000f3;n en Gerontolog&#x000ed;a, Guelatao No 66, Col. Ej&#x000e9;rcito de Oriente, 09230 M&#x000e9;xico, DF., M&#x000e9;xico, Tel +52 55 5623 0721, Fax +52 55 5773 6330, Email <email>mendovic@unam.mx</email></corresp></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>4</month><year>2018</year></pub-date><volume>13</volume><fpage>523</fpage><lpage>531</lpage><permissions><copyright-statement>&#x000a9; 2018 Mendoza-N&#x000fa;&#x000f1;ez et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2018</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>The antioxidant and anti-inflammatory effects of Tai chi (TC) exercise training in healthy older adults has been demonstrated. However, there are no studies on this effect in older adults with metabolic syndrome (MetS).</p></sec><sec><title>Purpose</title><p>The aim of this study was to determine the effect of TC exercise on oxidative stress and inflammatory markers in older adults with MetS.</p></sec><sec><title>Methods</title><p>A quasi-experimental study was carried out with a sample of 110 older sedentary volunteers with clinical diagnoses of MetS: (i) a control group, n = 50, of individuals who do not participate in physical exercise, of which 37 fulfilled the entire study protocol, and (ii) an experimental group, n = 60, of subjects enrolled in a TC exercise training program (eight-form easy), 5 days a week for 6 months, in sessions of 50 min, under the supervision of a qualified instructor, of which 48 fulfilled the entire study protocol. We measured in both groups (pre- and post-intervention) the following cardiovascular parameters: resting heart rate (RHR), diastolic and systolic blood pressure (DBP and SBP), mean arterial pressure (MAP), RHR-SBP product, RHR-MAP product; glycosylated hemoglobin (HbA1c); oxidative stress markers (superoxide dismutase, total antioxidant status, thiobarbituric acid reacting substances, and oxidative stress score); and inflammation markers (TNF-&#x003b1;, IL-6, IL-8, and IL-10).</p></sec><sec><title>Results</title><p>A statistically significant decrease in HbA1c concentration was observed in the TC group compared with the control group (<italic>p</italic> &#x0003c; 0.05). This group also showed a statistically significant increase in TAS and a decrease in the oxidative stress score (<italic>p</italic> &#x0003c; 0.05). We did not observe changes in the cardiovascular parameters (RHR, DBP, SBP, MAP, RHR-SBP product, and RHR-MAP product) in the TC experimental group compared to the control group.</p></sec><sec><title>Conclusion</title><p>Our findings suggest that the practice of TC exercise has an antioxidative and hypoglycemic effect in the elderly with MetS.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Tai chi</kwd><kwd>oxidative stress</kwd><kwd>older subjects</kwd><kwd>metabolic syndrome</kwd><kwd>HbA1c</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Metabolic syndrome (MetS) is a cluster of biochemical and clinical alterations characterized by insulin resistance, hyperinsulinemia, hyperglycemia, dyslipidemia, arterial hypertension, and obesity, in addition to the fact that MetS manifests in pro-thrombotic and proinflammatory states. In this sense, it has been shown that MetS has an increase in oxidative stress (OxS).<xref rid="b1-cia-13-523" ref-type="bibr">1</xref> The prevalence of MetS in young adults (20&#x02013;29 years) is less than 10%; however, in individuals &#x02265; 60 years of age, the prevalence increases to more than 40%.<xref rid="b2-cia-13-523" ref-type="bibr">2</xref>,<xref rid="b3-cia-13-523" ref-type="bibr">3</xref> MetS in older adults constitutes a risk factor for cognitive impairment and fragility linked to OxS and inflammaging.<xref rid="b4-cia-13-523" ref-type="bibr">4</xref>,<xref rid="b5-cia-13-523" ref-type="bibr">5</xref> For this reason, different therapeutic alternatives have been proposed, including the indication of metformin, melatonin, healthy diet, and physical exercise.<xref rid="b6-cia-13-523" ref-type="bibr">6</xref>&#x02013;<xref rid="b8-cia-13-523" ref-type="bibr">8</xref> In this sense, physical exercise has been shown to have a significant effect on weight loss and decreased glucose, cholesterol, and triglyceride levels and a decrease in OxS and proinflammatory markers in subjects with MetS.<xref rid="b9-cia-13-523" ref-type="bibr">9</xref></p><p>Therefore, different modalities of moderate physical exercise have been proposed as adjuvants for the prevention and control of MetS alterations in older adults, considering the decrease of OxS and chronic inflammation, among which, the practice of Tai chi (TC) is one of the more recommended forms of exercise.<xref rid="b10-cia-13-523" ref-type="bibr">10</xref>&#x02013;<xref rid="b12-cia-13-523" ref-type="bibr">12</xref></p><p>TC is a form of traditional Chinese exercise based on modified martial arts; it is classified as a moderate physical activity because its intensity does not exceed 55% of the maximum oxygen uptake and 60% of the maximum individual heart rate.<xref rid="b13-cia-13-523" ref-type="bibr">13</xref> TC training has been increased due to its beneficial effects on health, especially in the elderly. This exercise is characterized by a series of smooth and continuous movements, with precise execution of position control, deep breathing, and coordination of movements in the legs, arms, torso, and head. The practice of TC includes moving from one position to another at an equilibrium without stopping while also in a state of relaxation and concentration to achieve balance in movements.<xref rid="b14-cia-13-523" ref-type="bibr">14</xref></p><p>Our research group has identified antioxidant and anti-inflammatory effects of the practice of TC exercise in healthy older adults.<xref rid="b15-cia-13-523" ref-type="bibr">15</xref>,<xref rid="b16-cia-13-523" ref-type="bibr">16</xref> A beneficial effect of this physical exercise on OxS has also been reported in healthy young women and diabetic adults.<xref rid="b17-cia-13-523" ref-type="bibr">17</xref>,<xref rid="b18-cia-13-523" ref-type="bibr">18</xref> However, we do not know the effect of TC on OxS and proinflammatory markers in older adults with MetS. For this reason, the purpose of the present study was to evaluate the effect of TC exercise on OxS and inflammatory markers in older adults with MetS.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec sec-type="methods|subjects"><title>Subjects and design</title><p>The subjects were older, community-dwelling, Mexican mestizos who had been living in Mexico City for 5 years or more, were sedentary in the last 2 years, and with a clinical diagnosis of MetS, defined according to the criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.<xref rid="b20-cia-13-523" ref-type="bibr">20</xref></p><p>Informative brochures were distributed in the community specifying the objectives of the study and the admission criteria. A quasi-experimental study was performed with a sample of 150 subjects aged 60&#x02013;74 years. Those who were taking nutritional antioxidant supplements or anti-inflammatory drugs (n = 27) were excluded from the study, and 13 subjects refused to participate. All subjects agreed to participate in the study after signing a written informed consent form. The ethics committee of the Universidad Nacional Autonoma de Mexico, Zaragoza Campus, approved the research protocol for this study (IN306213-2).</p><p>An outline of the study can be seen in <xref ref-type="fig" rid="f1-cia-13-523">Figure 1</xref>. The sample was divided into two groups: (i) a control group (CG) with 50 subjects without physical exercise practice, of whom 37 fulfilled the entire study protocol and (ii) an experimental group (EG) with 60 subjects who performed exercise TC (eight-form easy),<xref rid="b19-cia-13-523" ref-type="bibr">19</xref> 5 days a week for 6 months, in sessions of 50 min, under the supervision of a qualified instructor, of whom 48 fulfilled the entire study protocol. The CG included people who were without physical exercise practice during the last 2 years, as well as the 6 months of this study. In this sense, the CG was constituted by people who self-reported that, at the moment, they did not have enough time to practice physical exercise and therefore could not participate in Tai Chi training; however, they expressed interest in participating in the biochemical tests that were carried out at the beginning and after 6 months and considered the possibility of participating in the program later.</p><p>All the participants of both the EG and CGs had the following variables measured at the beginning and after 6 months: dietary intake, anthropometric measurements, restoring heart rate and blood pressure, biochemical parameters (glucose, urate, albumin and lipid profile), plasma thiobarbituric acid-reactive substances, total plasma antioxidant status, red blood cell superoxide dismutase, red blood cell glutathione peroxidase, oxidative stress score (OxS-score) and inflammatory cytokines.</p></sec><sec><title>Dietary intake</title><p>All the subjects had a caloric intake between 3,000 and 3,500 kcal per day pre- and post-intervention measured by 24-h dietary total recall; nutrient intake (macronutrient and micronutrient) was analyzed using Food Processor<sup>&#x000ae;</sup> Nutrition Analysis Software. No subject took antioxidant supplements (vitamins or minerals) for at least 6 months prior to initiation of or during the study.</p></sec><sec><title>Anthropometric measurements</title><p>The anthropometric measurements of weight, height and waist circumference were obtained following a standardized protocol after recording the clinical history and conducting the physical examination. Weight was measured while the subject was wearing underwear and a hospital smock and was in a fasting state (after evacuation). A Torino<sup>&#x000ae;</sup> scale (Tecno L&#x000f3;gica Mexicana, Mexico City, Mexico), calibrated before each measurement, was used. Height was obtained with an aluminum cursor stadiometer graduated in millimeters. The subject was barefoot with the back and head in contact with the stadiometer in the Frankfurt horizontal plane. The body mass index (BMI) was calculated by dividing weight (kg) by height squared (m<sup>2</sup>). Waist circumference (cm) was measured to the nearest 0.5 cm with a tape measure at the umbilical scar level.</p></sec><sec><title>Resting heart rate and blood pressure</title><p>A 10-second 12-lead electrocardiograph was carried out to measure the resting heart rate (RHR) after the individual had rested in the supine position for 5 min. Blood pressure (BP) was measured following the standardized protocol according to the Official Mexican Norm (Norma Official Mexicana).<xref rid="b21-cia-13-523" ref-type="bibr">21</xref> Using a mercurial manometer at both arms, BP was registered before the training of TC (BP Baseline) and 6 months after (BP 6 months); measurements were taken in the morning in a fasted condition or 2 h after breakfast in sitting and standing positions. Subjects with pseudohypertension were identified by applying the Osler technique (feeling the radial pulse when the manometer registered values above the true systolic pressure). Mean arterial pressure (MAP) was calculated as diastolic blood pressure (DBP) plus one third of the difference of systolic blood pressure (SBP) minus the diastolic blood pressure. RHR-SBP product was calculated by (RHR &#x000d7; SBP); RHR-MAP product was calculated by (RHR &#x000d7; MAP). Blood pressure was taken by medical technicians who attended training sessions to standardize the procedures. The technicians were supervised to avoid possible biases in measurement.</p></sec><sec><title>Blood sampling and biochemical analyses</title><p>Blood samples were collected 1 week before the training of TC and 1 week after 6 months (in both groups, TC and CG) by venipuncture after a 10-h fasting period and placed in vacutainer/siliconized test tubes without anticoagulant for biochemical determinations (glucose, urate, albumin, lipid profile, and inflammatory cytokines) and with heparin for glycosylated hemoglobin (HbA1c) determination and OxS tests.</p><p>Glucose, urate, albumin, cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) concentration levels were determined using a Merck Vitalab Eclipse autoanalyzer (Merck, Dieren, the Netherlands). In particular, glucose levels were measured by the glucose oxidase method, and urate levels by the uricase colorimetric method. Albumin levels were measured with the bromocresol green technique.</p><p>The low-density lipoprotein cholesterol (LDL-C) was calculated by the Friedewald equation LDL = total cholesterol - (Triglycerides/5 + HDL).<xref rid="b22-cia-13-523" ref-type="bibr">22</xref> The reactive C protein was measured in serum by immunoturbidimetric assay.</p><p>HbA1c was measured in a whole blood sample with an immunoturbidimetric assay with an automated Selectra Junior clinical chemistry analyzer.</p><p>High and normal control sera were included as quality controls (Randox Laboratories, Ltd). The intra- and interassay variation coefficients were less than 5% for all determinations.</p></sec><sec><title>Plasma thiobarbituric acid-reactive substances</title><p>A thiobarbituric acid reacting substances (TBARS) assay was used as described in Jentzsch et al.<xref rid="b23-cia-13-523" ref-type="bibr">23</xref> In this assay, one molecule of malondialdehyde reacts with two molecules of thiobarbituric acid to produce a pink pigment with absorption at 535 nm. Amplification of peroxidation during the assay is prevented by the addition of the chain-breaking antioxidant butylated hydroxytoluene. Malondialdehyde standard (0.2&#x02013;4 &#x000b5;mol/L) was prepared either by hydrolysis of 1,1,3,3-tetramethoxypropane (Sigma-Aldrich Co., St Louis, MO, USA), or the samples (heparinized plasma, 400 &#x000b5;L) were mixed with 400 &#x000b5;L of orthophosphoric acid (0.2 mol/L; Sigma) and 50 &#x000b5;L of butylated hydroxytoluene (2 mmol/L; Sigma-Aldrich Co.); then, 50 &#x000b5;L of thiobarbituric acid reagent (0.11 mol/L in 0.1 mol/L NaOH) (Fluka Chemie GmbH, Buchs, Switzerland) was added and mixed. The contents were incubated at 90&#x000b0;C for 45 min in a water bath. Previously cooled (on ice to prevent further reaction) TBARS were extracted once with 1,000 &#x000b5;L of n-butanol (Sigma-Aldrich Co.). The upper butanol phase was read at 535 nm and 572 nm to correct for baseline absorption using a Shimadzu UV-1601 spectrophotometer (Shimadzu Corp., Kyoto, Japan). Malondialdehyde equivalents (TBARS) quantification was done with the calibration curve.</p></sec><sec><title>Plasma total antioxidant status</title><p>Plasma total antioxidant status (TAS) levels were quantified using 2,2&#x02032;-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) (Randox Laboratories Ltd), which is incubated with a peroxidase to produce the radical cation ABTS<sup>+</sup>. The bluish green staining of the ABTS<sup>+</sup> cation is relatively stable and measured at 600 nm; antioxidants present in the plasma cause suppression of this color production to a degree that is proportional to the concentration. The kinetics reaction was measured with a Shimadzu UV-1601 spectrophotometer (Shimadzu Corp., Kyoto, Japan).</p></sec><sec><title>Red blood cell superoxide dismutase</title><p>In this method, superoxide radicals are generated by employing xanthine and xanthine oxidase. The formed radical reacts with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride to form a red formazan color, which is measured at 505 nm. The superoxide dismutase (SOD) in the sample causes the inhibition of this reaction; the SOD activity is proportional to the degree of inhibition of the reaction (Randox Laboratories Ltd). Kinetics were measured with a Shimadzu UV-1601 spectrophotometer (Shimadzu Corp).</p></sec><sec><title>Red blood cell glutathione peroxidase</title><p>The glutathione peroxidase (GPx) catalyzes glutathione (GSH) oxidation by cumene hydroperoxide. In the presence of glutathione reductase (GR) and nicotinamide adenine dinucleotide phosphate (NADPH), oxidized GSH is immediately converted into the reduced form with a concomitant oxidation of NADPH to NADP<sup>+</sup> (Randox Laboratories Ltd). The decrease in absorbance is measured at 340 nm; we used a Shimadzu UV-1601 spectrophotometer (Shimadzu Corp.).</p><p>We calculated the SOD/GPx ratio and the Antioxidant gap (AOGAP) using the following equation:
<disp-formula id="fd1-cia-13-523"><mml:math id="mm1"><mml:mrow><mml:mtext>AOGAP</mml:mtext><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>TAS</mml:mtext><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>albumin</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mn>0.69</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mtext>uric&#x000a0;acid</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula><xref rid="b24-cia-13-523" ref-type="bibr">24</xref></p></sec><sec><title>Oxidative stress score</title><p>OxS was evaluated in relation to lipid peroxidation (LPO), SOD and GPx activities; TAS; SOD/GPx ratio; and AOGAP. On the basis of the 90th percentile of young healthy subjects, alternative cutoff values for each parameter were defined as follows: LPO &#x02265; 0.340 mmol/L; SOD &#x02264; 170 IU/mL; GPx &#x02264; 5,500 IU/L; TAS &#x02264; 0.9 mmol/L; SOD/GPx &#x02265; 0.023, and AOGAP &#x02264; 190 mmol/L. An OxS-score was established ranging from 1 to 6, representing the severity of biomarker modification; a score of 1 was given to each value beyond the cutoff. We categorized the subjects according to their OxS-score as follows: without OxS if OxS-score was 0 to 2 and with OxS if OxS-score was 3 to 6.<xref rid="b25-cia-13-523" ref-type="bibr">25</xref></p></sec><sec><title>Inflammatory cytokines</title><p>Aliquots of serum sample were assayed by flow cytometry via the Cytometric Bead Array (CBA) Human Inflammatory Cytokine Kit (BD Biosciences, San Jose, CA, USA) to determine the levels of interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF-&#x003b1;).<xref rid="b26-cia-13-523" ref-type="bibr">26</xref></p></sec><sec><title>TC exercise training program</title><p>The training program followed the guidelines established by Li et al<xref rid="b19-cia-13-523" ref-type="bibr">19</xref> for the practice of &#x0201c;Eight-form easy Tai chi for elderly adults,&#x0201d; which is 5 days a week, in sessions of 50 min each under the supervision of a qualified instructor for 6 months.</p><p>The participants had a 10-min warm-up, 30 min of practicing easy TC movements/postures, and a 5-min cool-down. Five-minute breaks between practice sessions were given to allow learners to rest and interact socially. After the warm-up, the participants held each single movement of the &#x0201c;Eight-form easy Tai chi for elderly adults&#x0201d; statically (in a stationary position) for a period of 5 to 10 s.</p><p>The &#x0201c;Eight-form easy Tai chi for elderly adults&#x0201d; to high stance is as follows: (i) Commencing form: both hands rise to shoulder level; (ii) curving back arms (repulse monkey): right, left; 3 times each side; (iii) stepping sideways and moving arms (Grasp Peacock&#x02019;s Tail: ward off, rollback, press, push): to the left, then to the right; (iv) moving hands (wave hands like &#x0201c;clouds moving in the sky&#x0201d;): left side leads, 3 times; (v) Diagonal strides (fair lady works at shuttles): left, then right; (vi) Standing on one leg (golden cock stands on one leg): right, then left; (vii) stepping and pushing (brush knees and twist steps): left, then right; (viii) closing form: both hands fall to the side, left leg drawn to the right leg.</p><p>Each movement was practiced repetitively (8&#x02013;10 repetitions) at a slow, self-controlled speed. After some successful initial practice of these static and moving positions, learners/ performers are ready to move on to linking the eight postures of easy TC in a sequential, continuous manner. Each daily session consisted of a minimum of five sets of easy TC, along with repeated practice of each movement.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Data analyses proceeded as follows: first, a descriptive analysis was performed to calculate the means and standard error (SE) of the outcomes over time. Second, a repeated measures multivariate analysis of variance was conducted to investigate the effects of the TC training program on changes of biochemical parameters, OxS and proinflammatory markers over time. The between-subject factor was each group (ie, the EG versus the CG), and the within-subject factor was time (baseline versus 6 months).<xref rid="b27-cia-13-523" ref-type="bibr">27</xref> To compare the frequency of OxS pre- and post-intervention, we used a chi-squared test. In the present study, the significance level (&#x003b1;) was set at &#x0003c; 0.05 for all statistical analyses. We used the statistical analysis program IBM SPSS Statistics 20.0.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Over the course of 6 months, no statistically significant differences were observed (<xref ref-type="table" rid="t1-cia-13-523">Table 1</xref>) in the TC practice group compared with the CG in the following measurements: RHR, DBP, SBP, MAP, RHR-SBP product, RHR-MAP product, body weight, and BMI.</p><p>Regarding the biochemical parameters, a statistically significant decrease in HbA1c concentration was observed in the TC group compared with the CG (<italic>p</italic> &#x0003c; 0.05), whereas no statistically significant differences were found in the blood levels of triglycerides, cholesterol, HDL, LDL, and glucose between the TC and CGs (<xref ref-type="table" rid="t2-cia-13-523">Table 2</xref>).</p><p>In respect to the OxS markers, the group that practiced TC showed a statistically significant increase in total antioxidant status and a decrease in the OxS grade compared with the CG (<italic>p</italic> &#x0003c; 0.05) (<xref ref-type="table" rid="t3-cia-13-523">Table 3</xref>). In this sense, the percentage of subjects with OxS detected in the TC group showed a statistically significant decrease (baseline, 56% vs TC, 23%, <italic>p</italic> &#x0003c; 0.01) in comparison with the CG (<xref ref-type="table" rid="t4-cia-13-523">Table 4</xref>).</p><p>In the measurement of markers of chronic inflammation, a statistically significant decrease in IL-8 was found in the group that practiced TC (baseline: 3.6 &#x000b1; 0.3 vs TC: 1.6 &#x000b1; 0.2 pg/mL, <italic>p</italic> &#x0003c; 0.01) (<xref ref-type="table" rid="t5-cia-13-523">Table 5</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Some chronic diseases of high prevalence in the elderly, such as diabetes mellitus type 2, cardiovascular diseases, cancer and Alzheimer&#x02019;s disease have been linked with MetS, in addition to accelerated aging and fragility. Likewise, OxS and chronic inflammation are biochemical alterations related to the etiology and complications of MetS and the abovementioned diseases.<xref rid="b28-cia-13-523" ref-type="bibr">28</xref>,<xref rid="b29-cia-13-523" ref-type="bibr">29</xref></p><p>It has been proposed that moderate physical exercise has a positive impact on OxS and inflammation during aging.<xref rid="b30-cia-13-523" ref-type="bibr">30</xref>,<xref rid="b31-cia-13-523" ref-type="bibr">31</xref> In this sense, it has been proven that regular practice of moderate physical exercise has a positive effect on the aging process, thus contributing to minimized biochemical changes related to aging and decreasing the risk of chronic diseases, therefore promoting health in aging individuals and increasing longevity.<xref rid="b32-cia-13-523" ref-type="bibr">32</xref>,<xref rid="b33-cia-13-523" ref-type="bibr">33</xref></p><p>Currently, the practice of TC is common to prevent and control chronic diseases of high prevalence in old age.<xref rid="b34-cia-13-523" ref-type="bibr">34</xref> In this sense, in some studies, a positive effect of TC training on RHR, SBP, DBP, MAP, and RHR-SBP product has been reported;<xref rid="b35-cia-13-523" ref-type="bibr">35</xref>&#x02013;<xref rid="b37-cia-13-523" ref-type="bibr">37</xref> however, in our study, no significant changes were observed in these parameters. This may be due to training time. In this regard, there is a study that has reported a positive effect on cardiovascular parameters after 2 years of TC training.<xref rid="b38-cia-13-523" ref-type="bibr">38</xref></p><p>On the other hand, in the present study, a statistically significant decrease in HbA1c concentration was observed in the CT group (<italic>p</italic> &#x0003c; 0.05). In this respect, this finding is congruent with what has been reported in some studies, suggesting that the hypoglycemic effect of CT is due to this type of physical activity, incorporating breathing techniques and body movement that burn calories.<xref rid="b12-cia-13-523" ref-type="bibr">12</xref>,<xref rid="b39-cia-13-523" ref-type="bibr">39</xref> However, the effectiveness of the practice of TC for the control of type 2 diabetes mellitus is still controversial, so further large-scale studies are needed to investigate the long-term efficacy of TC.<xref rid="b40-cia-13-523" ref-type="bibr">40</xref></p><p>Regarding control of dyslipidemias after TC training, a decrease in blood levels of triglycerides, total cholesterol, and LDL-C has been observed, as well as increased concentration of HDL-C.<xref rid="b15-cia-13-523" ref-type="bibr">15</xref>,<xref rid="b17-cia-13-523" ref-type="bibr">17</xref></p><p>However, in the present study, no statistically significant differences were observed in the biochemical markers mentioned above. In this sense, Pan et al<xref rid="b41-cia-13-523" ref-type="bibr">41</xref> reported in a meta-analysis of randomized controlled trials a statistically significant decrease in blood triglyceride concentration but found no statistically significant differences in total cholesterol, LDL-C, and HDL-C concentrations. Other studies support the proposal that there are no changes in parameters related to metabolic syndrome such as dyslipidemias, hyperglycemia, and waist circumference after TC training.<xref rid="b35-cia-13-523" ref-type="bibr">35</xref>,<xref rid="b37-cia-13-523" ref-type="bibr">37</xref> These inconsistencies justify carrying out longitudinal long-term studies on the effect of TC on the biochemical parameters related to metabolic syndrome in older adults.</p><p>Some studies have shown that MetS is associated with increased OxS.<xref rid="b1-cia-13-523" ref-type="bibr">1</xref>,<xref rid="b28-cia-13-523" ref-type="bibr">28</xref> In this sense, our research group, in a previous study, found that the number of MetS components is a significant risk factor in the development of OxS.<xref rid="b1-cia-13-523" ref-type="bibr">1</xref> Likewise, it has been demonstrated that the practice of moderate physical exercise has an antioxidant and anti-inflammatory effect in adult patients with MetS.<xref rid="b9-cia-13-523" ref-type="bibr">9</xref>,<xref rid="b42-cia-13-523" ref-type="bibr">42</xref> In addition, an antioxidant effect of TC practice has been observed in healthy adults and older adults.<xref rid="b15-cia-13-523" ref-type="bibr">15</xref>&#x02013;<xref rid="b18-cia-13-523" ref-type="bibr">18</xref> However, there are no studies on the antioxidant effect of TC in older adults with MetS. In the present study, we found a statistically significant increase in total antioxidant status activity (<italic>p</italic> &#x0003c; 0.01). This finding is similar to that reported in a study of healthy middle-aged people (40&#x02013;45 years of age), although in this study, they also observed a statistically significant decrease in LPO concentration and a statistically significant increase in SOD activity,<xref rid="b43-cia-13-523" ref-type="bibr">43</xref> in contrast to our results, where we found no statistically significant differences in LPO concentration and SOD activity between the group that performed TC and the control. These differences may be because our study was carried out in older persons with alterations of MetS. However, it is important to note that OxS is a dynamic process characterized by a biochemical imbalance caused by excessive production of reactive species, mainly of oxygen, that cannot be counteracted by antioxidant systems which causes oxidation of biomolecules. Therefore, OxS cannot be measured by isolated biochemical markers; as a result, an OxS score to measure the severity of OxS has been developed.<xref rid="b1-cia-13-523" ref-type="bibr">1</xref>,<xref rid="b25-cia-13-523" ref-type="bibr">25</xref> In this sense, our findings suggest that the antioxidant effect of TC is maintained in the elderly with MetS, with a 50% decrease in OxS score.</p><p>The mechanism suggests that the antioxidant effect of physical exercise changes the body&#x02019;s redox balance in favor of more alkaline conditions in the cell. The reactive species that generate during physical exercise act as a signal that is necessary for the activation of the MAPK proteins (p38 and ERK1/ERK2), which in turn activate the transcription factor sensitive to the redox state, nuclear factor kappa B (NF-&#x003ba;&#x003b2;), via activation of the kinase that phosphorylates the inhibitor of this factor (I&#x003ba;&#x003b2;). Once freed from its inhibitor, NF-&#x003ba;&#x003b2; migrates toward the nucleus where it can promote the synthesis of various antioxidant enzymes, such as MnSOD, iNOS, and glutamylcysteine synthetase.<xref rid="b44-cia-13-523" ref-type="bibr">44</xref> In this sense, the positive effects of TC may be due to the combination of various mechanisms, including the previously mentioned signaling. In addition to being a moderate form of exercise, it provides a relaxing psychological effect, similar to that reported in transcendental meditation. The practice of deep meditation (which is an essential characteristic of TC) is associated with lower levels of LPO, which has been explained as an effect of lower activity in the sympathetic nervous system. Another hypothesis suggests that profound meditation increases the levels of the hormone dehydroepiandrosterone, a marker of successful aging that has been linked with an increase in the activity of antioxidant enzymes.<xref rid="b45-cia-13-523" ref-type="bibr">45</xref>,<xref rid="b46-cia-13-523" ref-type="bibr">46</xref></p><p>The practice of moderate physical exercise, including TC, has a positive effect on markers of chronic inflammation.<xref rid="b9-cia-13-523" ref-type="bibr">9</xref>,<xref rid="b11-cia-13-523" ref-type="bibr">11</xref> In this regard, our study showed a statistically significant decrease in IL-8 levels in the TC group compared with the CG. In this sense, the IL-8 is a proinflammatory chemokine associated with the promotion of neutrophil chemotaxis and degranulation. The induction of IL-8 signaling activates multiple upstream signaling pathways that (i) impinge on gene expression via regulation of numerous transcription factor activities, (ii) modulate the cellular proteome at the level of translation, and/or (iii) affect the organization of the cell cytoskeleton through posttranslational regulation of regulatory proteins.<xref rid="b47-cia-13-523" ref-type="bibr">47</xref> In this regard, it has been demonstrated that increased serum concentrations of IL-8 are associated with poor memory and speed domain performance as well as decreased in motor function in elderly subjects.<xref rid="b48-cia-13-523" ref-type="bibr">48</xref> For this reason, the practice of TC also has an effect on maintaining and improving memory during the aging process.</p><p>Although the molecular changes related to the practice of TC linked to health are not completely clear, Buric et al (2017),<xref rid="b49-cia-13-523" ref-type="bibr">49</xref> as a result of a systematic review, conclude that TC as well as other mind&#x02013;body interventions (MBIs) are associated with the downregulation of NF-&#x003ba;&#x003b2; pathway. This is the opposite of the effects of chronic stress on gene expression and suggests that MBI practices may lead to a reduced risk of inflammation-related diseases. In this sense, MBIs have been shown to have a positive effect on the control of MetS;<xref rid="b50-cia-13-523" ref-type="bibr">50</xref> even the practice of TC for the prevention of MetS has been recommended.<xref rid="b11-cia-13-523" ref-type="bibr">11</xref></p><p>In conclusion, our findings suggest that the practice of TC in the elderly with MetS has antioxidative and hypoglycemic effects, so it could be recommended as a coadjuvant therapy for these patients. Nevertheless, it is important to note the limitations of the research, including the lack of monitoring of the type of alimentation, daily activities and psychosocial conditions faced by the participants during the study, all of which could influence the results.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Direcci&#x000f3;n General de Asuntos del Personal Acad&#x000e9;mico, Universidad Nacional Aut&#x000f3;noma de M&#x000e9;xico (DGAPA, UNAM), PAPIIT IN306213-2 &#x00026; Posgrado en Ciencias Biol&#x000f3;gicas, UNAM. We appreciate the support of Itzen Agui&#x000f1;iga-S&#x000e1;nchez for measured of inflammatory cytokines.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-cia-13-523"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Rodr&#x000ed;guez</surname><given-names>MA</given-names></name><name><surname>Mart&#x000ed;nez-Cruz</surname><given-names>M</given-names></name><name><surname>Correa-Mu&#x000f1;oz</surname><given-names>E</given-names></name><name><surname>Mendoza-N&#x000fa;&#x000f1;ez</surname><given-names>VM</given-names></name></person-group><article-title>Relationship between metabolic syndrome components and oxidative stress in elderly community-dwelling Mexicans</article-title><source>Ann Nutr Metab</source><year>2010</year><volume>56</volume><issue>4</issue><fpage>302</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">20530961</pub-id></element-citation></ref><ref id="b2-cia-13-523"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>SM</given-names></name></person-group><article-title>Metabolic syndrome pandemic</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2008</year><volume>28</volume><issue>4</issue><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">18174459</pub-id></element-citation></ref><ref id="b3-cia-13-523"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lechleitner</surname><given-names>M</given-names></name></person-group><article-title>Obesity and the metabolic syndrome in the elderly &#x02013; a mini-review</article-title><source>Gerontology</source><year>2008</year><volume>54</volume><issue>5</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">18841025</pub-id></element-citation></ref><ref id="b4-cia-13-523"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>BE</given-names></name><name><surname>Llabre</surname><given-names>MM</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><etal/></person-group><article-title>Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study</article-title><source>J Int Neuropsychol Soc</source><year>2014</year><volume>20</volume><issue>10</issue><fpage>951</fpage><lpage>960</lpage><pub-id pub-id-type="pmid">25382144</pub-id></element-citation></ref><ref id="b5-cia-13-523"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Roiland</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>DG</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name></person-group><article-title>Linking cognition and frailty in middle and old age: metabolic syndrome matters</article-title><source>Int J Geriatr Psychiatry</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">24733716</pub-id></element-citation></ref><ref id="b6-cia-13-523"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuf&#x000ed;</surname><given-names>S</given-names></name><name><surname>Vazquez-Martin</surname><given-names>A</given-names></name><name><surname>Oliveras-Ferraros</surname><given-names>C</given-names></name><name><surname>Martin-Castillo</surname><given-names>B</given-names></name><name><surname>Joven</surname><given-names>J</given-names></name><name><surname>Menendez</surname><given-names>JA</given-names></name></person-group><article-title>Metformin against TGF&#x003b2;-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis</article-title><source>Cell Cycle</source><year>2010</year><volume>9</volume><issue>22</issue><fpage>4461</fpage><lpage>4468</lpage><pub-id pub-id-type="pmid">21088486</pub-id></element-citation></ref><ref id="b7-cia-13-523"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardinali</surname><given-names>DP</given-names></name><name><surname>Hardeland</surname><given-names>R</given-names></name></person-group><article-title>Inflammaging, metabolic syndrome and melatonin: a call for treatment studies</article-title><source>Neuroendocrinology</source><year>2017</year><volume>104</volume><issue>4</issue><fpage>382</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">27165273</pub-id></element-citation></ref><ref id="b8-cia-13-523"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szarc vel Szic</surname><given-names>K</given-names></name><name><surname>Declerck</surname><given-names>K</given-names></name><name><surname>Vidakovi&#x00107;</surname><given-names>M</given-names></name><name><surname>Vanden Berghe</surname><given-names>W</given-names></name></person-group><article-title>From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?</article-title><source>Clin Epigenetics</source><year>2015</year><volume>7</volume><fpage>33</fpage><pub-id pub-id-type="pmid">25861393</pub-id></element-citation></ref><ref id="b9-cia-13-523"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farinha</surname><given-names>JB</given-names></name><name><surname>Steckling</surname><given-names>FM</given-names></name><name><surname>Stefanello</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome</article-title><source>Sports Med Open</source><year>2015</year><volume>1</volume><issue>1</issue><fpage>19</fpage><pub-id pub-id-type="pmid">26284160</pub-id></element-citation></ref><ref id="b10-cia-13-523"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>SS</given-names></name><name><surname>Xie</surname><given-names>YJ</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Chi-Yui Kwok</surname><given-names>T</given-names></name></person-group><article-title>Effects of Tai Chi and walking exercises on weight loss, metabolic syndrome parameters, and bone mineral density: a cluster randomized controlled trial</article-title><source>Evid Based Complement Alternat Med</source><year>2015</year><volume>2015</volume><fpage>976123</fpage><pub-id pub-id-type="pmid">26543489</pub-id></element-citation></ref><ref id="b11-cia-13-523"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Min</surname><given-names>X</given-names></name><etal/></person-group><article-title>Different physical activity subtypes and risk of metabolic syndrome in middle-aged and older Chinese people</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>e53258</fpage><pub-id pub-id-type="pmid">23308175</pub-id></element-citation></ref><ref id="b12-cia-13-523"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Miller</surname><given-names>YD</given-names></name><name><surname>Burton</surname><given-names>NW</given-names></name><name><surname>Brown</surname><given-names>WJ</given-names></name></person-group><article-title>A preliminary study of the effects of Tai Chi and Qigong medical exercise on indicators of metabolic syndrome, glycaemic control, health-related quality of life, and psychological health in adults with elevated blood glucose</article-title><source>Br J Sports Med</source><year>2010</year><volume>44</volume><issue>10</issue><fpage>704</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">18927159</pub-id></element-citation></ref><ref id="b13-cia-13-523"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JX</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>KM</given-names></name></person-group><article-title>Tai chi: physiological characteristics and beneficial effects on health</article-title><source>Br J Sports Med</source><year>2001</year><volume>35</volume><issue>3</issue><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">11375872</pub-id></element-citation></ref><ref id="b14-cia-13-523"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y</given-names></name></person-group><source>Tai Chi Chuan State of the art in international research <italic>Medicine Sports Science</italic></source><publisher-loc>Hong Kong</publisher-loc><publisher-name>Basel, Karger</publisher-name><year>2008</year></element-citation></ref><ref id="b15-cia-13-523"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosado-P&#x000e9;rez</surname><given-names>J</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name><name><surname>Ortiz</surname><given-names>R</given-names></name><name><surname>Mendoza-N&#x000fa;&#x000f1;ez</surname><given-names>VM</given-names></name></person-group><article-title>Tai chi diminishes oxidative stress in Mexican older adults</article-title><source>J Nutr Health Aging</source><year>2012</year><volume>16</volume><issue>7</issue><fpage>642</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">22836707</pub-id></element-citation></ref><ref id="b16-cia-13-523"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-N&#x000fa;&#x000f1;ez</surname><given-names>VM</given-names></name><name><surname>Hern&#x000e1;ndez-Monjaraz</surname><given-names>B</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name><name><surname>Betancourt-Rule</surname><given-names>JM</given-names></name><name><surname>Ruiz-Ramos</surname><given-names>M</given-names></name></person-group><article-title>Tai Chi exercise increases SOD activity and total antioxidant status in saliva and is linked to an improvement of periodontal disease in the elderly</article-title><source>Oxid Med Cell Longev</source><year>2014</year><volume>2014</volume><fpage>603853</fpage><pub-id pub-id-type="pmid">24790703</pub-id></element-citation></ref><ref id="b17-cia-13-523"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Ueng</surname><given-names>KC</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Sun</surname><given-names>KT</given-names></name><name><surname>Lee</surname><given-names>MC</given-names></name></person-group><article-title>Effect of T&#x02019;ai Chi exercise on biochemical profiles and oxidative stress indicators in obese patients with type 2 diabetes</article-title><source>J Altern Complement Med</source><year>2010</year><volume>16</volume><issue>11</issue><fpage>1153</fpage><lpage>1159</lpage><pub-id pub-id-type="pmid">20973735</pub-id></element-citation></ref><ref id="b18-cia-13-523"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>XY</given-names></name><name><surname>Eungpinichpong</surname><given-names>W</given-names></name><name><surname>Silsirivanit</surname><given-names>A</given-names></name><name><surname>Nakmareong</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>XH</given-names></name></person-group><article-title>Tai chi improves oxidative stress response and DNA damage/repair in young sedentary females</article-title><source>J Phys Ther Sci</source><year>2014</year><volume>26</volume><issue>6</issue><fpage>825</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">25013276</pub-id></element-citation></ref><ref id="b19-cia-13-523"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Fisher</surname><given-names>KJ</given-names></name><name><surname>Harmer</surname><given-names>P</given-names></name><name><surname>Shirai</surname><given-names>M</given-names></name></person-group><article-title>A simpler eight-form easy Tai chi for elderly adults</article-title><source>J Aging Phys Act</source><year>2003</year><volume>11</volume><fpage>206</fpage><lpage>218</lpage></element-citation></ref><ref id="b20-cia-13-523"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</collab></person-group><article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>3143</fpage><lpage>3421</lpage><pub-id pub-id-type="pmid">12485966</pub-id></element-citation></ref><ref id="b21-cia-13-523"><label>21</label><element-citation publication-type="book"><source>Secretar&#x000ed;a de Salud. Norma Oficial Mexicana NOM-030-SSA-1999, para la prevenci&#x000f3;n, tratamiento y control de la hipertensi&#x000f3;n arterial</source><publisher-loc>Mexico City</publisher-loc><publisher-name>Secretar&#x000ed;a de Salud</publisher-name><year>1999</year><comment>[Ministry of Health. Official Mexican Standard NOM-030-SSA-1999, for the prevention, treatment and control of arterial hypertension. Mexico City: Ministry of Health, 1999]. Spanish</comment></element-citation></ref><ref id="b22-cia-13-523"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="b23-cia-13-523"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jentzsch</surname><given-names>AM</given-names></name><name><surname>Bachmann</surname><given-names>H</given-names></name><name><surname>F&#x000fc;rst</surname><given-names>P</given-names></name><name><surname>Biesalski</surname><given-names>HK</given-names></name></person-group><article-title>Improved analysis of malondialdehyde in human body fluids</article-title><source>Free Radic Biol Med</source><year>1996</year><volume>20</volume><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">8746446</pub-id></element-citation></ref><ref id="b24-cia-13-523"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>NJ</given-names></name></person-group><article-title>Nonvitamin plasma antioxidants</article-title><person-group person-group-type="editor"><name><surname>Armstrong</surname><given-names>D</given-names></name></person-group><source>Free Radical and Antioxidant Protocols</source><publisher-loc>Totowa, NJ</publisher-loc><publisher-name>Humana Press</publisher-name><year>1998</year><fpage>285</fpage><lpage>297</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1385/0-89603-472-0:285">https://doi.org/10.1385/0-89603-472-0:285</ext-link></comment><date-in-citation>Accessed February 28, 2018</date-in-citation></element-citation></ref><ref id="b25-cia-13-523"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Rodr&#x000ed;guez</surname><given-names>MA</given-names></name><name><surname>Ruiz-Ramos</surname><given-names>M</given-names></name><name><surname>Mendoza-N&#x000fa;&#x000f1;ez</surname><given-names>VM</given-names></name></person-group><article-title>Proposal of a construct to measure severity of oxidative stress</article-title><source>Free Radic Biol Med</source><year>2006</year><volume>41</volume><fpage>S29</fpage></element-citation></ref><ref id="b26-cia-13-523"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>EB</given-names></name><name><surname>Stahl</surname><given-names>JL</given-names></name><name><surname>Lowe</surname><given-names>L</given-names></name><etal/></person-group><article-title>Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics</article-title><source>J Immunol Methods</source><year>2001</year><volume>254</volume><issue>1&#x02013;2</issue><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">11406157</pub-id></element-citation></ref><ref id="b27-cia-13-523"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Ki</surname><given-names>CS</given-names></name></person-group><article-title>Correct use of repeated measures analysis of variance</article-title><source>Korean J Lab Med</source><year>2009</year><volume>29</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19262072</pub-id></element-citation></ref><ref id="b28-cia-13-523"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonomini</surname><given-names>F</given-names></name><name><surname>Rodella</surname><given-names>LF</given-names></name><name><surname>Rezzani</surname><given-names>R</given-names></name></person-group><article-title>Metabolic syndrome, aging and involvement of oxidative stress</article-title><source>Aging Dis</source><year>2015</year><volume>6</volume><issue>2</issue><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">25821639</pub-id></element-citation></ref><ref id="b29-cia-13-523"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaffe</surname><given-names>K</given-names></name></person-group><article-title>Metabolic syndrome and cognitive disorders: is the sum greater than its parts?</article-title><source>Alzheimer Dis Assoc Disord</source><year>2007</year><volume>21</volume><issue>2</issue><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">17545744</pub-id></element-citation></ref><ref id="b30-cia-13-523"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArdle</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>MJ</given-names></name></person-group><article-title>Exercise, oxidative stress and ageing</article-title><source>J Anat</source><year>2000</year><volume>197</volume><fpage>539</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">11197526</pub-id></element-citation></ref><ref id="b31-cia-13-523"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radak</surname><given-names>Z</given-names></name><name><surname>Chung</surname><given-names>HY</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name></person-group><article-title>Exercise and hormesis: oxidative stress- related adaptation for successful aging</article-title><source>Biogerontology</source><year>2005</year><volume>6</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">15834665</pub-id></element-citation></ref><ref id="b32-cia-13-523"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassey</surname><given-names>EJ</given-names></name></person-group><article-title>The benefits of exercise for the health of older people</article-title><source>Rev Clin Gerontol</source><year>2000</year><volume>10</volume><fpage>17</fpage><lpage>31</lpage></element-citation></ref><ref id="b33-cia-13-523"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>MAF</given-names></name></person-group><article-title>Exercise and aging</article-title><source>Clin Geriatr Med</source><year>2004</year><volume>20</volume><fpage>201</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">15182878</pub-id></element-citation></ref><ref id="b34-cia-13-523"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huston</surname><given-names>P</given-names></name><name><surname>McFarlane</surname><given-names>B</given-names></name></person-group><article-title>Health benefits of tai chi: what is the evidence?</article-title><source>Can Fam Physician</source><year>2016</year><volume>62</volume><issue>11</issue><fpage>881</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">28661865</pub-id></element-citation></ref><ref id="b35-cia-13-523"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>R</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>AS</given-names></name><name><surname>Sze</surname><given-names>SL</given-names></name></person-group><article-title>A Chinese Chan-based mind-body intervention improves psychological well-being and physical health of community-dwelling elderly: a pilot study</article-title><source>Clin Interv Aging</source><year>2014</year><volume>9</volume><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">24790425</pub-id></element-citation></ref><ref id="b36-cia-13-523"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>GY</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wayne</surname><given-names>PM</given-names></name><name><surname>Phillips</surname><given-names>RS</given-names></name></person-group><article-title>The effect of tai chi exercise on blood pressure: a systematic review</article-title><source>Prev Cardiol</source><year>2008</year><volume>11</volume><issue>2</issue><fpage>82</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">18401235</pub-id></element-citation></ref><ref id="b37-cia-13-523"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Buys</surname><given-names>N</given-names></name></person-group><article-title>Community-based mind-body meditative Tai Chi program and its effects on improvement of blood pressure, weight, renal function, serum lipoprotein, and quality of life in Chinese adults with hypertension</article-title><source>Am J Cardiol</source><year>2015</year><volume>116</volume><issue>7</issue><fpage>1076</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">26251005</pub-id></element-citation></ref><ref id="b38-cia-13-523"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueroa</surname><given-names>MA</given-names></name><name><surname>DeMeersman</surname><given-names>RE</given-names></name><name><surname>Manning</surname><given-names>J</given-names></name></person-group><article-title>The autonomic and rate pressure product responses of Tai chi practitioners</article-title><source>N Am J Med Sci</source><year>2012</year><volume>4</volume><fpage>270</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">22754878</pub-id></element-citation></ref><ref id="b39-cia-13-523"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>LW</given-names></name><name><surname>Li</surname><given-names>TC</given-names></name><name><surname>Hwu</surname><given-names>YJ</given-names></name><name><surname>Chang</surname><given-names>SC</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name><name><surname>Chang</surname><given-names>PY</given-names></name></person-group><article-title>The effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: A systematic review and meta-analysis</article-title><source>Diabetes Res Clin Pract</source><year>2016</year><volume>113</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">26822261</pub-id></element-citation></ref><ref id="b40-cia-13-523"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>JH</given-names></name><name><surname>Gu</surname><given-names>WJ</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name></person-group><article-title>Lack of evidence on Tai Chi-related effects in patients with type 2 diabetes mellitus: a meta-analysis</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2013</year><volume>121</volume><issue>5</issue><fpage>266</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">23450333</pub-id></element-citation></ref><ref id="b41-cia-13-523"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>XH</given-names></name><name><surname>Mahemuti</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><etal/></person-group><article-title>Effect of Tai Chi exercise on blood lipid profiles: a meta-analysis of randomized controlled trials</article-title><source>J Zhejiang Univ Sci B</source><year>2016</year><volume>17</volume><issue>8</issue><fpage>640</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">27487809</pub-id></element-citation></ref><ref id="b42-cia-13-523"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stensvold</surname><given-names>D</given-names></name><name><surname>Sl&#x000f8;rdahl</surname><given-names>SA</given-names></name><name><surname>Wisl&#x000f8;ff</surname><given-names>U</given-names></name></person-group><article-title>Effect of exercise training on inflammation status among people with metabolic syndrome</article-title><source>Metab Syndr Relat Disord</source><year>2012</year><volume>10</volume><issue>4</issue><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">22455564</pub-id></element-citation></ref><ref id="b43-cia-13-523"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>A</given-names></name></person-group><article-title>Effect of &#x0201c;Tai Chi&#x0201d; exercise on antioxidant enzymes activities and immunity function in middle-aged participants</article-title><source>Afr J Tradit Complement Altern Med</source><year>2016</year><volume>13</volume><issue>5</issue><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">28487898</pub-id></element-citation></ref><ref id="b44-cia-13-523"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Cabrera</surname><given-names>MC</given-names></name><name><surname>Domenech</surname><given-names>E</given-names></name><name><surname>Vi&#x000f1;a</surname><given-names>J</given-names></name></person-group><article-title>Moderate exercise is an antioxidant: upregulation of antioxidant genes by training</article-title><source>Free Radic Biol Med</source><year>2008</year><volume>44</volume><issue>2</issue><fpage>126</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">18191748</pub-id></element-citation></ref><ref id="b45-cia-13-523"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epel</surname><given-names>E</given-names></name><name><surname>Daubenmier</surname><given-names>J</given-names></name><name><surname>Moskowitz</surname><given-names>JT</given-names></name><name><surname>Folkman</surname><given-names>S</given-names></name><name><surname>Blackburn</surname><given-names>E</given-names></name></person-group><article-title>Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres</article-title><source>Ann N Y Acad Sci</source><year>2009</year><volume>1172</volume><fpage>34</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">19735238</pub-id></element-citation></ref><ref id="b46-cia-13-523"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahagita</surname><given-names>C</given-names></name></person-group><article-title>Roles of meditation on alleviation of oxidative stress and improvement of antioxidant system</article-title><source>J Med Assoc Thai</source><year>2010</year><volume>93</volume><issue>Suppl 6</issue><fpage>S242</fpage><lpage>S254</lpage><pub-id pub-id-type="pmid">21280542</pub-id></element-citation></ref><ref id="b47-cia-13-523"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waugh</surname><given-names>DJ</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name></person-group><article-title>The interleukin-8 pathway in cancer</article-title><source>Clin Cancer Res</source><year>2008</year><volume>14</volume><issue>21</issue><fpage>6735</fpage><lpage>6741</lpage><pub-id pub-id-type="pmid">18980965</pub-id></element-citation></ref><ref id="b48-cia-13-523"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baune</surname><given-names>BT</given-names></name><name><surname>Ponath</surname><given-names>G</given-names></name><name><surname>Golledge</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association between IL-8 cytokine and cognitive performance in an elderly general population &#x02013; the MEMO-Study</article-title><source>Neurobiol Aging</source><year>2008</year><volume>29</volume><issue>6</issue><fpage>937</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">17207897</pub-id></element-citation></ref><ref id="b49-cia-13-523"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buric</surname><given-names>I</given-names></name><name><surname>Farias</surname><given-names>M</given-names></name><name><surname>Jong</surname><given-names>J</given-names></name><name><surname>Mee</surname><given-names>C</given-names></name><name><surname>Brazil</surname><given-names>IA</given-names></name></person-group><article-title>What is the molecular signature of mind-body interventions? A systematic review of gene expression changes induced by meditation and related practices</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>670</fpage><pub-id pub-id-type="pmid">28670311</pub-id></element-citation></ref><ref id="b50-cia-13-523"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JG</given-names></name><name><surname>Taylor</surname><given-names>AG</given-names></name></person-group><article-title>The metabolic syndrome and mind-body therapies: a systematic review</article-title><source>J Nutr Metab</source><year>2011</year><volume>2011</volume><fpage>276419</fpage><pub-id pub-id-type="pmid">21773016</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-cia-13-523" position="float"><label>Figure 1</label><caption><p>Outline of the study.</p></caption><graphic xlink:href="cia-13-523Fig1"/></fig><table-wrap id="t1-cia-13-523" position="float"><label>Table 1</label><caption><p>Clinical and anthropometric parameters by study group</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Parameters</th><th valign="top" align="left" rowspan="1" colspan="1">Control<break/>(n = 37)</th><th valign="top" align="left" rowspan="1" colspan="1">Tai chi<break/>(n = 48)</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">68.2 &#x000b1; 6.6</td><td valign="top" align="left" rowspan="1" colspan="1">67.4 &#x000b1; 4.7</td><td valign="top" align="left" rowspan="1" colspan="1">0.77</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Weight (kg)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">68.0 &#x000b1; 1.5</td><td valign="top" align="left" rowspan="1" colspan="1">69.7 &#x000b1; 1.7</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">68.9 &#x000b1; 1.6</td><td valign="top" align="left" rowspan="1" colspan="1">69.3 &#x000b1; 1.8</td><td valign="top" align="left" rowspan="1" colspan="1">0.49</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">28.3 &#x000b1; 0.5</td><td valign="top" align="left" rowspan="1" colspan="1">30.2 &#x000b1; 0.7</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">28.7 &#x000b1; 0.6</td><td valign="top" align="left" rowspan="1" colspan="1">30.0 &#x000b1; 0.7</td><td valign="top" align="left" rowspan="1" colspan="1">0.83</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RHR (beats per minute)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">64.0 &#x000b1; 8.3</td><td valign="top" align="left" rowspan="1" colspan="1">64.3 &#x000b1; 10.9</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">67.6 &#x000b1; 10.1</td><td valign="top" align="left" rowspan="1" colspan="1">67.4 &#x000b1; 11.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.84</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">131.8 &#x000b1; 2.6</td><td valign="top" align="left" rowspan="1" colspan="1">127.6 &#x000b1; 3.0</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">132.8 &#x000b1; 2.1</td><td valign="top" align="left" rowspan="1" colspan="1">129.4 &#x000b1; 2.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.57</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DBP (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">76.3 &#x000b1; 1.0</td><td valign="top" align="left" rowspan="1" colspan="1">78.6 &#x000b1; 1.9</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">80.8 &#x000b1; 1.3</td><td valign="top" align="left" rowspan="1" colspan="1">79.5 &#x000b1; 1.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.53</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MAP (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">6,026.7 &#x000b1; 1,019.5</td><td valign="top" align="left" rowspan="1" colspan="1">6,147.5 &#x000b1; 1,377.7</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">6,525.5 &#x000b1; 1,001.9</td><td valign="top" align="left" rowspan="1" colspan="1">6,538.3 &#x000b1; 1,452.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.79</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RHR-SBP product</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">8,389.1 &#x000b1; 1,540.0</td><td valign="top" align="left" rowspan="1" colspan="1">8,301.1 &#x000b1; 2,029.0</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">8,841.1 &#x000b1; 1,487.3</td><td valign="top" align="left" rowspan="1" colspan="1">8,814.1 &#x000b1; 2,024.0</td><td valign="top" align="left" rowspan="1" colspan="1">0.88</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RHR-MAP product</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">6,026.7 &#x000b1; 1,019.5</td><td valign="top" align="left" rowspan="1" colspan="1">6,147.5 &#x000b1; 1,377.7</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">6,525.5 &#x000b1; 1,001.9</td><td valign="top" align="left" rowspan="1" colspan="1">6,538.3 &#x000b1; 1,452.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.79</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-cia-13-523"><p><bold>Notes:</bold> Values are means &#x000b1; SE. Repeated measures analysis of variance.</p></fn><fn id="tfn2-cia-13-523"><p><bold>Abbreviations:</bold> DBP, diastolic blood pressure; MAP, mean arterial pressure; RHR, resting heart rate; RHR-MAP product, resting heart rate &#x000d7; mean arterial pressure; RHR-SBP product, resting heart rate &#x000d7; systolic blood pressure; SE, standard error; SBP, systolic blood pressure.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-cia-13-523" position="float"><label>Table 2</label><caption><p>Biochemical parameters by study group</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Parameters</th><th valign="top" align="left" rowspan="1" colspan="1">Control<break/>(n = 37)</th><th valign="top" align="left" rowspan="1" colspan="1">Tai chi<break/>(n = 48)</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Glucose (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">113.3 &#x000b1; 4.2</td><td valign="top" align="left" rowspan="1" colspan="1">121.8 &#x000b1; 3.4</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">109.4 &#x000b1; 4.3</td><td valign="top" align="left" rowspan="1" colspan="1">120.0 &#x000b1; 3.5</td><td valign="top" align="left" rowspan="1" colspan="1">0.73</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Urate (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">4.4 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">5.2 &#x000b1; 0.3</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">4.8 &#x000b1; 0.4</td><td valign="top" align="left" rowspan="1" colspan="1">5.4 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.67</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Albumin (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">4.5 &#x000b1; 0.1</td><td valign="top" align="left" rowspan="1" colspan="1">4.4 &#x000b1; 0.09</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">4.8 &#x000b1; 0.07</td><td valign="top" align="left" rowspan="1" colspan="1">4.7 &#x000b1; 0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.87</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cholesterol (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">202.2 &#x000b1; 6.7</td><td valign="top" align="left" rowspan="1" colspan="1">209.4 &#x000b1; 4.9</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">192.2 &#x000b1; 7.3</td><td valign="top" align="left" rowspan="1" colspan="1">210.1 &#x000b1; 4.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.46</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HDL-C (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">45.5 &#x000b1; 1.4</td><td valign="top" align="left" rowspan="1" colspan="1">42.6 &#x000b1; 0.9</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">53.9 &#x000b1; 1.7</td><td valign="top" align="left" rowspan="1" colspan="1">50.8 &#x000b1; 1.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LDL-C (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">120.0 &#x000b1; 5.4</td><td valign="top" align="left" rowspan="1" colspan="1">132.6 &#x000b1; 3.2</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">100.2 &#x000b1; 5.7</td><td valign="top" align="left" rowspan="1" colspan="1">120.1 &#x000b1; 3.6</td><td valign="top" align="left" rowspan="1" colspan="1">0.13</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HbA1c (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">7.0 &#x000b1; 0.3</td><td valign="top" align="left" rowspan="1" colspan="1">8.2 &#x000b1; 0.3</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">6.9 &#x000b1; 0.4</td><td valign="top" align="left" rowspan="1" colspan="1">7.3 &#x000b1; 0.3</td><td valign="top" align="left" rowspan="1" colspan="1">0.03</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-cia-13-523"><p><bold>Notes:</bold> Values are means &#x000b1; SE. Repeated measures analysis of variance.</p></fn><fn id="tfn4-cia-13-523"><p><bold>Abbreviations:</bold> HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SE, standard error.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-cia-13-523" position="float"><label>Table 3</label><caption><p>Oxidative stress markers by study group</p></caption><table frame="hsides" rules="groups"><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Markers</td><td valign="top" align="left" rowspan="1" colspan="1">Control<break/>(n = 37)</td><td valign="top" align="left" rowspan="1" colspan="1">Tai chi<break/>(n = 48)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic>-value</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lipoperoxides (&#x000b5;mol/L)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">0.29 &#x000b1; 0.02</td><td valign="top" align="left" rowspan="1" colspan="1">0.30 &#x000b1; 0.01</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">0.34 &#x000b1; 0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.33 &#x000b1; 0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.82</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SOD (UI/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">179.0 &#x000b1; 1.4</td><td valign="top" align="left" rowspan="1" colspan="1">178.7 &#x000b1; 1.8</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">173.7 &#x000b1; 2.1</td><td valign="top" align="left" rowspan="1" colspan="1">173.9 &#x000b1; 1.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GPx (UI/L)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">7,670 &#x000b1; 856</td><td valign="top" align="left" rowspan="1" colspan="1">7,427 &#x000b1; 509</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">9,564 &#x000b1; 794</td><td valign="top" align="left" rowspan="1" colspan="1">9,616 &#x000b1; 501</td><td valign="top" align="left" rowspan="1" colspan="1">0.96</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SOD/GPx</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">0.030 &#x000b1; 0.005</td><td valign="top" align="left" rowspan="1" colspan="1">0.028 &#x000b1; 0.002</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">0.025 &#x000b1; 0.004</td><td valign="top" align="left" rowspan="1" colspan="1">0.021 &#x000b1; 0.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.61</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TAS (mmol/L)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">0.85 &#x000b1; 0.02</td><td valign="top" align="left" rowspan="1" colspan="1">1.03 &#x000b1; 0.04</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 &#x000b1; 0.04</td><td valign="top" align="left" rowspan="1" colspan="1">1.28 &#x000b1; 0.02</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AOGAP (&#x000b5;mol/L)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">171.7 &#x000b1; 23.6</td><td valign="top" align="left" rowspan="1" colspan="1">228.3 &#x000b1; 38.0</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">356.1 &#x000b1; 60.0</td><td valign="top" align="left" rowspan="1" colspan="1">427.5 &#x000b1; 32.3</td><td valign="top" align="left" rowspan="1" colspan="1">0.56</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OxS-score</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Baseline</td><td valign="top" align="left" rowspan="1" colspan="1">2.69 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">2.28 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Six months</td><td valign="top" align="left" rowspan="1" colspan="1">2.23 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 &#x000b1; 0.1</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-cia-13-523"><p><bold>Notes:</bold> Values are means &#x000b1; SE. Repeated measures analysis of variance.</p></fn><fn id="tfn6-cia-13-523"><p><bold>Abbreviations:</bold> AOGAP, antioxidant GAP; GPx, glutathione peroxidase; OxS-score, oxidative stress score; SE, standard error; SOD, superoxide dismutase; TAS, total antioxidant status.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-cia-13-523" position="float"><label>Table 4</label><caption><p>Frequency of oxidative stress pre- and post-intervention</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Control
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Tai chi
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Baseline, n (%)</th><th valign="top" align="left" rowspan="1" colspan="1">Six months, n (%)</th><th valign="top" align="left" rowspan="1" colspan="1">Baseline, n (%)</th><th valign="top" align="left" rowspan="1" colspan="1">Six months, n (%)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Without OxS</td><td valign="top" align="left" rowspan="1" colspan="1">14 (38)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (57)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (44)</td><td valign="top" align="left" rowspan="1" colspan="1">37 (77)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">With OxS</td><td valign="top" align="left" rowspan="1" colspan="1">23 (62)</td><td valign="top" align="left" rowspan="1" colspan="1">16 (43)</td><td valign="top" align="left" rowspan="1" colspan="1">27 (56)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (23)<xref ref-type="table-fn" rid="tfn8-cia-13-523">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn7-cia-13-523"><p><bold>Note:</bold> Chi-squared test:</p></fn><fn id="tfn8-cia-13-523"><label>*</label><p><italic>p</italic> &#x0003c; 0.01.</p></fn><fn id="tfn9-cia-13-523"><p><bold>Abbreviation:</bold> OxS, oxidative stress.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-cia-13-523" position="float"><label>Table 5</label><caption><p>Inflammatory markers by study group</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Markers</th><th valign="top" align="left" rowspan="1" colspan="1">Control<break/>(n = 37)</th><th valign="top" align="left" rowspan="1" colspan="1">Tai chi<break/>(n = 48)</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">IL-6 (pg/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pre-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.24 &#x000b1; 0.1</td><td valign="top" align="left" rowspan="1" colspan="1">0.97 &#x000b1; 0.1</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Post-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.39 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">1.28 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IL-8 (pg/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pre-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">4.6 &#x000b1; 0.5</td><td valign="top" align="left" rowspan="1" colspan="1">3.6 &#x000b1; 0.3</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Post-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">5.9 &#x000b1; 0.7</td><td valign="top" align="left" rowspan="1" colspan="1">1.6 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IL-10 (pg/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pre-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.5 &#x000b1; 0.05</td><td valign="top" align="left" rowspan="1" colspan="1">1.6 &#x000b1; 0.02</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Post-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.4 &#x000b1; 0.08</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 &#x000b1; 0.10</td><td valign="top" align="left" rowspan="1" colspan="1">0.17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TNF-&#x003b1; (pg/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pre-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.9 &#x000b1; 0.02</td><td valign="top" align="left" rowspan="1" colspan="1">2.1 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Post-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.05</td><td valign="top" align="left" rowspan="1" colspan="1">2.0 &#x000b1; 0.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.87</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRP (mg/dL)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pre-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">0.21 &#x000b1; 0.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 &#x000b1; 0.04</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Post-intervention</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 &#x000b1; 0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.39 &#x000b1; 0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.51</td></tr></tbody></table><table-wrap-foot><fn id="tfn10-cia-13-523"><p><bold>Notes:</bold> Values are means &#x000b1; SE. Repeated measures analysis of variance.</p></fn><fn id="tfn11-cia-13-523"><p><bold>Abbreviations:</bold> CRP, C-reactive protein; IL-10, interleukin 10; IL-6, interleukin 6; IL-8, interleukin 8; SE, standard error; TNF-&#x003b1;, tumor necrosis factor alpha.</p></fn></table-wrap-foot></table-wrap></floats-group></article>